Johnson Chemical Pharmaceutical Works Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 07:10 pm
Share
Johnson Chemical Pharmaceutical Works Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 97.459 million compared to TWD 101.245 million a year ago. Operating income was TWD 18.335 million compared to TWD 17.057 million a year ago. Net income was TWD 17.728 million compared to TWD 14.509 million a year ago. Basic earnings per share was TWD 0.59 compared to TWD 0.48 a year ago. For the half year, sales was TWD 215.245 million compared to TWD 202.739 million a year ago. Operating income was TWD 41.042 million compared to TWD 35.360 million a year ago. Net income was TWD 36.067 million compared to TWD 29.303 million a year ago. Basic earnings per share was TWD 1.2 compared to TWD 0.98 a year ago.
Johnson Chemical Pharmaceutical Works Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of western medicines and the related raw materials. The Company mainly provides solid dosage forms, including soft and hard capsules, sugar coated tablets, film-coated tablets, suppositories, powder, granules, tablets and others. The Companyâs products include central nervous system drugs, hormones and hormone function medicines, respiratory medicines, gastrointestinal drugs, vitamins and others. The Company mainly distributes its products in Taiwan market and the rest of Asia.
JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD. 
